Myla Health’s service description extends beyond the first menopause appointment. It explains a later written summary, a route for brief questions and a separately charged review. That makes the interval between appointments a useful focus for someone deciding how private care would fit alongside an existing GP relationship.
This September 28, 2026 review concerns the published UK service, not firsthand treatment. Myla requires patients to be on UK soil at the appointment and to have a UK address for medicine delivery. Its video option therefore does not establish US access, and a recommendation sent to an NHS GP does not guarantee NHS prescribing.
Understand the first appointment’s time and purpose
Myla’s services page describes an initial consultation of around 45 minutes, in person or by video, discussing symptoms and their effect on daily life. Its pricing page also describes telephone consultations. The actual format and clinician should be confirmed when booking rather than inferred from the broad service description.
The consultation is an opportunity to consider options, not an obligation to accept treatment immediately. Myla says patients who need more time can return to the discussion within three months. The Newson Clinic review offers another UK appointment model, with separate clinician categories and fees rather than an identical private-care package.
Sending records does not guarantee an advance clinical review
The Myla FAQ welcomes relevant records, letters and results through the patient account or the clinic’s specified contact route. It expressly says advance review is not guaranteed and that information is usually considered during the appointment. That distinction matters when a person is relying on an older investigation to explain a current concern.
The FAQ also limits responsibility for investigations not requested or formally reviewed as part of Myla’s care. If a result needs urgent attention, it directs the patient to the professional who requested it. The bleeding-history guide supports clear preparation, but this publication does not assess a result or decide that waiting for a booked consultation is appropriate.
Use the conversation to describe impact, not just a label
The service description emphasizes symptoms and their impact before discussing treatment. That gives the appointment a purpose beyond confirming a presumed hormone problem. The hot-flash and sleep guide helps distinguish a daily-life difficulty from a broad wish to feel better.
A separate description of vaginal discomfort may also matter, as explored in the vaginal-symptom visit guide. Myla’s published material says blood tests are not usually required before assessment, while allowing them to be arranged when appropriate. That is the clinic’s stated approach, not advice for a reader to obtain, cancel or ignore tests requested by another professional.
The written summary is a useful handoff, with limits
Myla says on its services page that it writes within the next week to summarize the discussion and treatment plan and sends this to the GP. This is a published process, not a delivery deadline verified for an individual appointment. A reader can ask what to do if the summary is missing or does not reflect their understanding.
The FAQ explains that Myla can issue private prescriptions and may request NHS prescribing, but the GP is not obliged to accept that request. Local policies also matter. The letter therefore supports communication; it does not by itself establish that another clinician has accepted continuing treatment responsibility or that private medicine charges have ended.
Separate quick questions from another appointment
The FAQ describes email as suitable for clarifications and brief questions while settling into a plan. More complex matters may require a follow-up appointment. This is a useful boundary, because access to an email address is not the same as unlimited clinical review or an emergency service.
Myla describes a review around three months after starting care, with additional appointments when needed. It requires an annual review if it continues prescribing and a longer new appointment after more than eighteen months away. These are published service arrangements, not a personal treatment schedule. Defy’s review provides a contrasting US model in which intake, monitoring and later contacts are organized differently.
The review and medicine costs remain separate
The pricing page lists £290 for the initial consultation and £190 for a 30-minute follow-up, with those prices stated as applying from April 1, 2026. It says private prescriptions carry no administration charge in the first three months, while the pharmacy still charges for medicine. Later private prescriptions incur a £35 administration charge.
The FAQ says payment is taken at booking and describes conditional insurance arrangements. NHS availability should not be used to erase those private costs before a GP has agreed to prescribe. A reader needs an explanation of the review, any medicine purchase and possible continuing private charges as distinct parts of the decision.
Check cancellation wording and the plan if care is delayed
Myla’s FAQ describes a full cancellation charge with less than 24 hours’ notice, a half-fee category using two working days and a no-fee statement referring to more than 48 hours. Working days and elapsed hours can differ, so the clinic should clarify the applicable boundary before a time-sensitive change. This review does not silently convert them into one deadline.
The same FAQ says an interim private prescription may be possible if a review is delayed, provided the clinician considers it appropriate and there are no new concerns. That is conditional, not automatic cover. Before the appointment ends, establish how to report a delay and who is responsible for the next clinical decision.
Read alongside the article
Sources & notes.
These sources provide provider descriptions or medical context. They do not replace an individual clinical assessment.
- Our Women's Health Services | Myla Health ↗Primary UK consultation and follow-up process; published timings are not independently tested · Checked 2026-09-28
- Myla Health: pricing effective April 1, 2026 ↗UK provider pricing page · Checked 2026-09-28
- Myla Health: appointment, prescription and access FAQs ↗UK provider care and administrative policy · Checked 2026-09-28